Loading...
Golimumab for Rheumatoid Arthritis
Since the advent of infliximab for the treatment of rheumatoid arthritis (RA), new genetically-engineered molecules have appeared. This review aims to present the current data and body of evidence for golimumab (GLM). Safety, efficacy, tolerability and immunogenicity are all being investigated, not...
Saved in:
| Published in: | J Clin Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463251/ https://ncbi.nlm.nih.gov/pubmed/30897745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8030387 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|